Assessing an AAV gene therapy for an ophthalmic indication

Challenge: We were asked to conduct an assessment of an AAV gene therapy for an ophthalmic indication, focusing on market potential, technical and regulatory issues and the identification of key...
Learn More

In-licensing due diligence for a respiratory drug

Challenge A pharma company needed help conducting due diligence on an in-licensing/acquisition candidate for a Phase IIb respiratory drug.
Learn More

Assessment of a blood product

Challenge A life science venture capital fund was contemplating investing in advanced plasma product opportunities being developed by a biopharmaceutical company, and needed a reality check on the...
Learn More

Providing due diligence for an Alzheimer’s treatment

Challenge: Our client, a major pension fund, was considering an investment in a Phase III neuroscience company, which was developing a small molecule to provide symptomatic relief of Alzheimer’s...
Learn More

Preparing an expert review paper

Challenge A venture-backed biotech company developing a clinical stage asset for the treatment of early-stage cancer was populating a data room and preparing for negotiations with a major pharma...
Learn More

Regulatory affairs due diligence in EU

Challenge An established generics company looking to acquire the French rights of an existing product franchise needed to perform regulatory and clinical due diligence on the French dossier.
Learn More

Point of care diagnostics due diligence

Challenge A major European venture capital investor needed to analyze the business plan of a novel point-of-care diagnostics company.
Learn More

Development strategy and business support for an early-stage oncology company

Challenge After a seed investment, Evgen, a start-up biotech had built an IP portfolio in the field of glucosinolates, chemicals found in brassica vegetables, that are potent inducers of...
Learn More

Conducting IP due diligence

Challenge We have conducted multiple due diligence projects, below are three examples:
Learn More

Assessment of an AAV gene therapy for an ophthalmic indication

Challenge: Alacrita conducted an assessment of an AAV gene therapy for an ophthalmic indication, focusing on market potential, technical and regulatory issues and identification of key risks.
Learn More

Neuroscience Due Diligence

Alzheimer's due diligence Our client, a major pension fund, was considering an investment opportunity in a Phase III neuroscience company. The company was developing a small molecule to provide...
Learn More

Supporting due diligence on regulatory affairs in the respiratory field

Challenge: A clinical stage biotech needed support with its regulatory due diligence activities for products in the respiratory field.
Learn More